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Letters to the Editor 
Dear Editor 
Quality of life in a cross-over design 
As a parameter, quality of life (QOL) has become 
more common in clinical trials. The focus has 
been on the reliability and validity of the chosen 
tests, their ability to discriminate between different 
groups of respondents, and administrative simplicity. 
Less attention has been paid to the design and 
methodology of the study. 
Impaired QOL should be a part of the inclusion 
criteria. The randomized groups should be compar- 
able. The duration of treatment should be long 
enough to make sure that an effect is possible. In a 
cross-over study, the washout period should be long 
enough to remove any carry-over effect. The required 
washout period can be difficult to predict, and may 
differ for various parameters of QOL. This is one of 
our conclusions from a clinical trial (1). 
In this cross-over trial, salmeterol was compared 
with salbutamol controlled release (salb. CR) in 59 
asthmatic patients. Carry-over effect was found for 
QOL, but not for peak expiratory flow rate, symptom 
score or additional use of salbutamol. Analyses were 
carried out on three scores derived from the ‘Living 
With Asthma Questionnaire’ (LWAQ): (1) the over- 
all score (OS); (2) the problem subscale score (PSS); 
and (3) the evaluation subscale score (ESS) (2). 
When results were analysed without reference to 
the order of treatment, we found that, for OS and 
PSS, there was a significant difference between run-in 
and salmeterol and between run-in and salb. CR, but 
there was no difference between salmeterol and salb. 
CR. However, there was also a significant difference 
between run-in and washout, suggesting either a trial 
effect or some carry-over effect from the active 
treatment. In the case of ESS, the only significant 
difference was between run-in and salmeterol. 
When the order of treatment was taken into 
account, we found a significant effect of treatment 
order for the ESS. This was not the case for OS and 
PSS. The results show that patients treated initially 
with salmeterol showed an improvement on the ESS, 
but those treated initially with salb. CR did not show 
an improvement, in fact there was a non-significant 
deterioration. The reason for this finding is not clear 
but one possibility could be that the initial treatment 
with salb. CR, in spite of the washout period, pre- 
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vented the positive effect of salmeterol. This pos- 
sibility should be treated with caution and, at this 
stage, should only be considered as an area for 
further investigation. 
T. RINGBAEK 
Bispebjerg Hospital 
Copenhagen, Denmark 
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Dear Editor 
Pulmonary alveolar proteinosis and disseminated 
Mycobacterium avium infection 
Pulmonary alveolar protelnosis (PAP) is a rare 
disorder characterized by accumulation of phospho- 
lipidic material in the alveolar space (l), which can be 
‘idiopathic’ or secondary to various conditions, such 
as malignant haematologic disorders (2). Recently, 
isolation of Mycobacterium avium intra cellulare 
(MAI) has been reported in patients with PAP, 
suggesting that defective alveolar macrophage func- 
tion linked to PAP contributed to the higher fre- 
quency of pulmonary MA1 infection (3). As a further 
contribution, we report a woman with PAP and a 
MA1 bone-marrow and lymph-node infection but 
without MA1 pulmonary involvement. 
We have previously reported the case of a 32-year- 
old female (4) who developed fever, weight loss, 
cervical lymph nodes and pancytopenia (white blood 
cells count: 1.8 x lo9 1 - ’ with 63% neutrophils, 25% 
lymphocytes, 5% monocytes, 5% eosinophils; haemo- 
globin 7.8 g dl- ‘; platelets 135 x 10” 1~ I). Numer- 
ous caseous necrotic granuloma were seen in the 
lymph nodes and bone marrow with Ziehl-Nielsen 
positive bacilli. Culture of bone marrow was positive 
for MAI. Chest X-ray studies showed a miliary 
pattern. Bronchoalveolar lavage and sputum culture 
were negative for mycobacteria as well as for 
other pathogens. No acquired illness or primary 
immunodeficiency was found that could explain this 
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opportunistic infection (the patient had been repeat- 
edly sero-negative for HIV-l and HIV-2; culture and 
polymerase chain reaction on peripheral blood 
mononuclear cells and alveolar cells remained nega- 
tive for HIV; there was no evidence of a proliferative 
disorder on computed tomographic scan of the 
thorax, abdomen and pelvis). No auto-antibodies 
were detected; adenosine deaminase and purine 
nucleoside phosphorylase activities, and serum 
a-foetoprotein level were normal. CD4+lymphocyte 
count was moderately decreased (308 mm - ‘) with a 
normal proliferative response to mitogens. 
One year later, the patient deteriorated with 
cachexia, persistance of fever and an increasing pul- 
monary interstitial infiltrate. Repeated broncho- 
alveolar lavage analysis and cultures were negative 
for all pathogens. Analysis of bronchoalveolar lav- 
by analysis of bronchoalveolar lavage and open 
lung biopsy (1,5). This case is different from those 
reported previously, which associate PAP and 
pulmonary myobacterial infection. To our knowl- 
edge, no other such case has been reported. This 
case suggests that patients with PAP must be 
examined for MA1 pulmonary and extra-pulmonary 
infection. 
L. J. COUDERC*, J.-F. BERNAUDIN~, B. EPARDEAU* 
AND I. CAUBARRERE* 
*Hopital Foch 
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